Norma Y Hernández-Pedro

8PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers 2021, 13, 6256.

|Oct 16, 2025
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers 2021, 13, 6256.

Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana

|Sep 27, 2025
Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612.

Norma Hernández-Pedro, Marisol Arroyo-Hernández, Pedro Barrios-Bernal

|Feb 06, 2025
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy.

Maritza Ramos-Ramírez, Enrique Caballe-Pérez, José Lucio-Lozada

|Dec 05, 2024
Real-World Survival Outcomes in Non-Small Cell Lung Cancer: The Impact of Genomic Testing and Targeted Therapies in a Latin American Middle-Income Country.

Juan-Manuel Hernandez-Martinez, Alberto Guijosa, Diana Flores-Estrada

|Oct 28, 2023
Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer.

Norma Hernández-Pedro, Marisol Arroyo-Hernández, Pedro Barrios-Bernal

Pageof 2

Frequent Collaborators

8 joint publications

Oscar Arrieta

4 joint publications

Eunice Romero-Núñez

3 joint publications

Enrique Caballé-Perez

3 joint publications

Pedro Barrios-Bernal